A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
Latest Information Update: 30 Oct 2023
At a glance
- Drugs Methylphenidate (Primary)
- Indications Agoraphobia; Anxiety disorders; Attention-deficit hyperactivity disorder; Major depressive disorder; Panic disorder; Seasonal affective disorder
- Focus Therapeutic Use
- 24 Oct 2023 Status changed from recruiting to completed.
- 30 May 2019 Status changed from not yet recruiting to recruiting.
- 02 Jan 2019 New trial record